Development and Validation of the Nursing Home Minimum Data Set 3.0 Mortality Risk Score (MRS3)

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 74, Issue 2, 2019, Pages 219-225

  Thomas, Kali S ^a,b   Ogarek, Jessica A ^b   Teno, Joan M ^c   Gozalo, Pedro L ^a,b   Mor, Vincent ^a,b  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Mortality; Nursing home; Prognosis; Risk adjustment

Indexed keywords

ADULT; ARTICLE; CALIBRATION; CHARLSON COMORBIDITY INDEX; CLINICAL ASSESSMENT; CLINICIAN; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY RATE; MORTALITY RISK; NURSING HOME; PROGNOSIS; RISK ASSESSMENT; SAMPLE SIZE; STATISTICS; UNITED STATES; VALIDATION PROCESS; AGED; CAUSE OF DEATH; EPIDEMIOLOGY; FOLLOW UP; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE; NURSING HOMES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 85060061890     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gly044     Document Type: Article

References (44)

1. Liu K, Wissoker D, Swett A. Nursing home use by dual-eligible beneficiaries in the last year of life. Inquiry. 2007;44:88-103. doi:10.5034/ inquiryjrnl-44.1.88
2. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88-93. doi:10.1001/jama.291.1.88
3. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998;279:1709-1714. doi:10.1001/jama.279.21.1709
4. Murphy DJ, Burrows D, Santilli S, et al. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med. 1994;330:545-549. doi:10.1056/ NEJM199402243300807
5. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ. 2006;333:1091. doi:10.1136/bmj.38985.646481.55
6. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
7. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69-81.
8. Gawande AA, Kwaan MR, Regenbogen SE, Lipsitz SA, Zinner MJ. An Apgar score for surgery. J Am Coll Surg. 2007;204:201-208. doi:10.1016/j. jamcollsurg.2006.11.011
9. Sobol JB, Gershengorn HB, Wunsch H, Li G. The surgical Apgar score is strongly associated with intensive care unit admission after high-risk intraabdominal surgery. Anesth Analg. 2013;117:438-446. doi:10.1213/ ANE.0b013e31829180b7
10. Reynolds PQ, Sanders NW, Schildcrout JS, Mercaldo ND, St Jacques PJ. Expansion of the surgical Apgar score across all surgical subspecialties as a means to predict postoperative mortality. Anesthesiology. 2011;114:1305-1312. doi:10.1097/ALN.0b013e318219d734.
11. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27:563-572. doi:10.1097/QAD.0b013e32835b8c7f
12. Justice AC, Modur SP, Tate JP, et al.; NA-ACCORD and VACS Project Teams. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: A North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62:149-163. doi:10.1097/ QAI.0b013e31827df36c
13. Kline JA, Roy PM, Than MP, et al. Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res. 2012;129:e194-e199. doi:10.1016/j. thromres.2012.03.015
14. van der Hulle T, den Exter PL, Kooiman J, van der Hoeven JJ, Huisman MV, Klok FA. Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. J Thromb Haemost. 2014;12:1116-1120. doi:10.1111/jth.12605
15. Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: A systematic approach based on risk group. Trials. 2006;7:30. doi:10.1186/1745-6215-7-30
16. Hernandez AV, Steyerberg EW, Habbema JD. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004;57:454-460. doi:10.1016/j.jclinepi.2003.09.014
17. Hernandez AV, Eijkemans MJ, Steyerberg EW. Randomized controlled trials with time-to-event outcomes: How much does prespecified covariate adjustment increase power? Ann Epidemiol. 2006;16:41-48. doi:10.1016/j.annepidem.2005.09.007
18. Iezzoni LI. Risk Adjustment for Measuring Health Care Outcomes. 3rd ed. Chicago, IL: Health Administration Press; 2003.
19. Iezzoni L. Risk Adjustment for Measuring Health Care Outcomes. 4th ed. Chicago, IL: Health Administration Press; 2012.
20. Centers for Medicare & Medicaid Services. MDS 3.0 RAI Manual. 2017.
21. Mitchell SL, Kiely DK, Hamel MB, Park PS, Morris JN, Fries BE. Estimating prognosis for nursing home residents with advanced dementia. JAMA. 2004;291:2734-2740. doi:10.1001/jama.291.22.2734
22. Mitchell SL, Miller SC, Teno JM, Davis RB, Shaffer ML. The advanced dementia prognostic tool: A risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage. 2010;40:639-651. doi:10.1016/j.jpainsymman.2010.02.014
23. Abicht-Swensen LM, Debner LK. The minimum data set 2.0: A functional assessment to predict mortality in nursing home residents. Am J Hosp Palliat Care. 1999;16:527-532. doi:10.1177/104990919901600308
24. Flacker JM, Kiely DK. Mortality-related factors and 1-year survival in nursing home residents. J Am Geriatr Soc. 2003;51:213-221. doi:10.1046/j.1532-5415.2003.51060.x
25. Porock D, Oliver DP, Zweig S, et al. Predicting death in the nursing home: Development and validation of the 6-month Minimum Data Set mortality risk index. J Gerontol A Biol Sci Med Sci. 2005;60:491-498. doi:10.1093/ gerona/60.4.491
26. Brink P, Kelley ML. Death in long-term care: A brief report examining factors associated with death within 31 days of assessment. Palliat Care. 2015;9:1-5. doi:10.4137/PCRT.S20347
27. van Dijk PT, Mehr DR, Ooms ME, et al. Comorbidity and 1-year mortality risks in nursing home residents. J Am Geriatr Soc. 2005;53:660-665. doi:10.1111/j.1532-5415.2005.53216.x
28. Levy C, Kheirbek R, Alemi F, et al. Predictors of six-month mortality among nursing home residents: Diagnoses may be more predictive than functional disability. J Palliat Med. 2015;18:100-106. doi:10.1089/ jpm.2014.0130
29. Porock D, Parker-Oliver D, Petroski GF, Rantz M. The MDS mortality risk index: The evolution of a method for predicting 6-month mortality in nursing home residents. BMC Res Notes. 2010;3:200. doi:10.1186/1756-0500-3-200
30. Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS scale: A new measure to predict mortality in institutionalized older people. J Am Geriatr Soc. 2003;51:96-100. doi:10.1034/j.1601-5215.2002.51017.x
31. Saliba D, Buchanan J. Making the investment count: Revision of the Minimum Data Set for nursing homes, MDS 3.0. J Am Med Dir Assoc. 2012;13(7):602-610. doi:10.1016/j.jamda.2012.06.002
32. Saliba D, Buchanan J, Edelen MO, et al. MDS 3.0: Brief interview for mental status. J Am Med Dir Assoc. 2012;13(7):611-617. doi:10.1016/j. jamda.2012.06.004
33. Saliba D, DiFilippo S, Edelen MO, Kroenke K, Buchanan J, Streim J. Testing the PHQ-9 interview and observational versions (PHQ-9 OV) for MDS 3.0. J Am Med Dir Assoc. 2012;13:618-625. doi:10.1016/j. jamda.2012.06.003
34. Saliba D, Jones M, Streim J, Ouslander J, Berlowitz D, Buchanan J. Overview of significant changes in the Minimum Data Set for nursing homes version 3.0. J Am Med Dir Assoc. 2012;13:595-601. doi:10.1016/j. jamda.2012.06.001
35. Kosar CM, Thomas KS, Inouye SK, Mor V. Delirium during postacute nursing home admission and risk for adverse outcomes. J Am Geriatr Soc. 2017;65:1470-1475. doi:10.1111/jgs.14823
36. Rahman M, Tyler D, Acquah JK, Lima J, Mor V. Sensitivity and specificity of the Minimum Data Set 3.0 discharge data relative to Medicare claims. J Am Med Dir Assoc. 2014;15:819-824. doi:10.1016/j.jamda.2014.06.017
37. Thomas KS, Dosa D, Wysocki A, Mor V. The Minimum Data Set 3.0 cognitive function scale. Med Care. 2017;55(9):e68-e72. doi:10.1097/ MLR.0000000000000334
38. Thomas KS, Wysocki A, Intrator O, Mor V. Finding gertrude: The resident's voice in Minimum Data Set 3.0. J Am Med Dir Assoc. 2014;15(11):802-806. doi:10.1016/j.jamda.2014.01.012
39. Wysocki A, Thomas KS, Mor V. Functional improvement among shortstay nursing home residents in the MDS 3.0. J Am Med Dir Assoc. 2015;16:470-474. doi:10.1016/j.jamda.2014.11.018
40. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50:419-430. doi:10.1002/ bimj.200710415
41. Wei YJ, Simoni-Wastila L, Zuckerman IH, Brandt N, Lucas JA. Algorithm for identifying nursing home days using medicare claims and minimum data set assessment data. Med Care. 2016;54:e73-e77. doi:10.1097/ MLR.0000000000000109
42. Ritt M, Jager J, Ritt JI, Sieber CC, Gasmann KG. Operationalizing a frailty index using routine blood and urine tests. Clin Interv Aging. 2017;12:1029-1040. doi:10.2147/CIA.S131987
43. Rockwood K, Mitnitski AB, MacKnight C. Some mathematical models of frailty and their clinical implications. Rev Clin Gerontol. 2002;12:109-117. doi:10.1017/S0959259802012236
44. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489-495. doi:10.1503/ cmaj.050051